查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1858256

动脉动脉粥状硬化斑块切除术器械市场：2025-2032年全球预测（按器械类型、应用、最终用户和方式划分）

Atherectomy Devices Market by Device Type, Application, End-User, Mode Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，动脉粥状硬化斑块切除术设备市场将成长至 20.2 亿美元，复合年增长率为 8.69%。

关键市场统计数据
基准年 2024 10.3亿美元
预计年份：2025年 11.2亿美元
预测年份 2032 20.2亿美元
复合年增长率 (%) 8.69%

全面介绍器材创新、临床实务变革与诊疗路径需求如何重塑介入医师的动脉粥状斑块切除动脉粥状硬化斑块切除术格局。

动脉粥状硬化斑块切除术装置在现代週边和冠状动脉介入治疗中发挥着至关重要的作用，能够有效治疗传统球囊血管成形术和支架置放术难以根治的钙化和复杂动脉粥状硬化病变。临床上对精准斑块修整的需求，以及对提高手术效率和最大限度减少后续併发症的追求，推动了斑块切除装置的不断发展。创新技术涵盖机械式、定向式、轨道式和雷射系统，每种系统都旨在应对不同的病变形态和解剖结构挑战，同时适应临床医生的偏好和医疗机构的工作流程。

除了器械机制之外，相关人员的期望如今还扩展到能够缩短手术时间、降低栓塞风险并促进当日出院的综合解决方案。医疗保险报销环境、手术指南以及对门诊介入治疗日益增长的需求正在重塑这些器械的应用地点和方式。随着临床团队追求最佳患者疗效，他们在选择动脉粥状硬化斑块切除术方案时，越来越重视手术的相对安全性、易用性、培训要求以及对术后护理的影响。

随着新一代治疗模式（例如连续和间歇性治疗）的引入，以及栓塞保护和血管内成像等辅助技术的日益复杂，决策矩阵正变得愈发多样化。因此，器械製造商、临床领导者和医疗系统采购人员必须应对一个复杂的局面：临床疗效、营运适应性和监管合规性共同决定影响手术路径和患者照护轨蹟的策略选择。

临床影像、门诊护理趋势和器械机械差异化如何推动动脉粥状硬化斑块切除术手术策略和应用过程的根本性变革

动脉粥状硬化斑块切除术领域的变革性变化反映了临床、技术和医疗服务趋势的交汇融合，这些趋势正在重新定义手术模式。随着血管内影像和生理评估工具指南器械选择，临床医生正在采用更精准的病变准备策略，从而推动个人化治疗方案的实施，使器械的力学特性与斑块成分相匹配。这导致定向、雷射、轨道和旋转系统等器械之间的差异化程度不断提高，每种器械都根据病变的复杂性和解剖因素，开闢了特定的临床应用领域。

同时，医疗服务模式正向门诊和流动医疗机构转变，这使得使用者人体工学、缩短手术时间以及与当日出院通讯协定的兼容性成为器械研发的优先事项。器械运作模式（例如连续模式和间歇模式）之间的相互作用会影响热量输出、碎片处理和操作技术，迫使製造商创新安全功能和辅助栓塞保护策略。此外，血管外科医生、介入性心臟病专家和放射科医生之间的跨学科合作正在加速利用互补器械平台的混合手术方法的发展。

在商业方面，随着各公司专注于服务交付、培训项目和降低用户接受门槛的捆绑式解决方案，竞争日趋激烈。监管审查的加强和报销机制的不断演变也促使各公司加强投入，以提案并产生真实世界数据。这些变化共同推动动脉动脉粥状硬化斑块切除术的应用范围从小众介入扩展到更广泛的、主导通讯协定为导向的治疗路径，从而优先考虑可预测的治疗结果和手术效率。

2025年美国关税变化对营运和采购的影响：重塑医疗器材相关人员的采购、製造和临床应用路径

美国关税调整将于2025年生效，对医疗设备供应链的各个环节都提出了具体的营运要求，影响到动脉粥状硬化斑块切除术系统的关键组件、资本财进口以及週边耗材。这些关税调整迫使製造商重新评估筹资策略，优先考虑区域供应的连续性，并加快与委託製造製造商的磋商，以保障生产计划。对于那些依赖美国境外专业组件或组装流程的公司而言，这种调整尤其显着，促使它们将生产外包到美国附近地区，并实现供应商组合多元化。

为此，医院、门诊手术中心和专科诊所的采购部门在选择医疗器材平台时，更加重视库存管理、合约条款和整体拥有成本。医疗设备製造商则透过材料清单清单审查、在临床可行的情况下简化设计以及选择性地在地采购采购高价值组件来优化成本。此外，製造商也加强与医疗系统的对话，探索寄售模式、库存管理方案和批量采购协议，以减轻关税造成的价格波动。

这项政策转变也促使企业重新关註生命週期支援和服务型收入来源，力求在提供可预测采购方案的同时维持利润率。重点，临床医生和供应链领导者正携手合作，确保在应对关税环境变化带来的营运调整时，临床疗效和病人安全始终是重中之重。这促成了医疗设备和耗材领域切实可行的权衡取舍和分阶段实施策略。

关键细分市场分析揭示了医疗设备机制、临床适应症、护理环境和操作模式如何共同影响临床应用和商业性定位。

细分市场分析揭示了不同设备类型、临床应用、终端用户环境和操作模式所带来的细微动态，从而为临床策略和商业性策略的发展提供了基础。不同类型的设备——定向定向通常用于偏心病灶中斑块的精确修整；雷射系统在某些纤维钙化病灶中具有独特的优势；轨道式平台能够以差异化的切割方式进行环週斑块打磨；而旋转式系统则因其熟悉度和在特定病灶群体中久经考验的性能而被广泛选择。这些机械差异会影响训练需求、手术方案规划和辅助设备的选择。

适应症细分突显了冠状动脉通路和周边通路之间的明显差异。冠状动脉介入治疗通常优先考虑小口径、高流量血管的管腔重建，而周边血管手术则需要具备处理较大血管和各种病变形态的灵活性。在周边通路中，颈动脉介入治疗和下肢动脉介入治疗的特殊考量指导临床决策。在下肢策略中，解剖结构活动度、血管大小和动态应力因素进一步区分了腘动脉和股浅动脉介入治疗。最终使用者细分突显了医疗环境对器械选择和物流流程的影响。门诊手术中心强调手术量和当日出院资格，医院优先考虑器械适用范围和备用资源，而专科诊所则专注于以血管为中心的流程。在专科诊所中，门诊血管中心和血管实验室面临不同的人员配置和影像基础设施的考量，这些因素会影响器械的应用。

连续运转和间歇运转模式的差异会影响操作技术和安全性。连续系统可提供稳定的性能，适用于特定的斑块形态，而间歇系统可能具有温度控管优势或不同的碎屑特性。全面考虑这些区别将有助于制定市场推广策略、临床培训计划和价值提案，以满足不同临床和地理环境下操作者和机构的独特需求。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势将影响临床路径、监管方法和商业性合作策略。

区域趋势对动脉粥状硬化斑块切除术器械的临床实践模式、监管方法和商业策略有着显着影响，美洲、欧洲、中东和非洲以及亚太地区呈现出不同的特征。在美洲，先进的血管内介入治疗计画和成熟的介入医师网络正在塑造临床路径，促使三级医疗中心的手术量大幅增长，并扩大了门诊的手术能力。该地区的报销机制和供应链因素影响采购速度，有利于那些能够提供完善培训和全生命週期支援的合作伙伴。

欧洲、中东和非洲地区（EMEA）法规环境和医疗服务模式的多样性要求企业采取适应性强的市场策略。西欧医疗机构往往优先考虑实证实践、血管内影像技术的整合以及多学科的手术方案规划，而该地区的其他市场则可能更注重成本效益高的解决方案和扩充性的培训计画。监管时间表和当地采购惯例是决定打入市场策略和产品定位的关键因素。

在亚太地区，不断扩大的心血管医疗基础设施、微创技术的快速普及以及公私医疗服务相结合的模式，正在创造多元化的机会。在多个市场，周边动脉疾病手术量的成长以及导管室投资的增加，催生了对功能多样的医疗器材产品组合的需求。在所有地区，製造商和临床领导者都必须调整全球产品平台，使其适应当地的临床工作流程、监管要求和报销实际情况，并采用差异化的合作模式，使培训、服务和商业性支援与区域优先事项保持一致。

製造商如何透过临床培训、服务模式和整合平台策略来竞争，从而影响手术流程的采用和长期客户关係？

医疗设备製造商之间的竞争不再局限于器材本身，而是涵盖了培训、实证医学证据、上市后监测以及综合服务等领域。主要企业正加大对临床教育计画、介入团队实践培训以及支持患者选择和手术方案规划的数位化工具的投入。这些措施有助于降低器械应用门槛，并增强不同器械类型转换过程中医护人员的手术信心。策略伙伴关係和分销模式也在不断发展，製造商与医疗系统、培训中心和影像设备供应商合作，建构涵盖从方案规划到术后追踪整个手术流程的综合解决方案。

产品研发投资的重点在于提昇平台的多功能性、增强辅助安全功能（例如与栓塞保护装置的兼容性）以及改进微创入路技术。各公司也透过真实世界数据倡议和註册登记参与来加强临床证据，并支持与支付方就疗效和资源利用情况展开的讨论。库存管理、现场技术支援和以疗效为导向的培训等差异化服务是关键的竞争优势，尤其是在手术量和成本可预测性会影响采购决策的环境下。

随着临床需求和营运限制相互交织，能够将产品设计、临床医生培训和售后支援与机构工作流程相契合的市场参与者，将更有利于影响长期采购决策。那些优先考虑血管内成像和周边设备互通性、能够证明临床结果可重复性并提供可扩展教育项目的公司，将更有利于在复杂的客户环境中保持可持续的竞争优势。

针对医疗设备製造商和临床领导者的实用建议：将培训、供应链韧性和实证实践与社区医疗保健优先事项相结合

产业领导者应采取多管齐下的方法，将器材创新与临床教育、在地化适应性和稳健的供应链结合。首先，他们应优先投资于全面的临床医生培训项目，这些项目应结合模拟、指导和案例式学习，以加速定向、雷射、轨道和旋转平台整体器械的安全应用。将血管内影像训练与器械教育结合，将使临床医生能够优化患者选择和手术流程，减少手术结果的差异，并为特定器械的治疗方案提供更有力的临床证据。

第二，我们将透过多元化零件采购管道、探索关键组件的近岸外包以及与医疗系统合作伙伴协商灵活的采购条款，来增强供应链的韧性。这些措施将减轻贸易政策变化带来的营运不确定性，并支持可预测的医疗器材供应。第三，我们将根据区域监管和报销环境调整策略，并提供灵活的商业模式，例如库存管理、试点按绩效付费合约以及社区服务点，以满足门诊手术中心、医院和专科诊所（包括门诊血管中心和血管实验室）的独特需求。

第四，我们将加快对真实世界证据项目和註册登记的投资，以收集冠状动脉和外周血管领域的介入治疗结果，重点关注特定病变部位，特别是涉及颈动脉、腘动脉和股浅动脉的下肢血管介入治疗。最后，我们将制定产品蓝图，在效能提升和易用性之间取得平衡，强调连续和间歇模式下的安全特性，以满足不同操作者的偏好。这种综合方法将使製造商和临床领导者能够将创新转化为永续的应用，并改善患者照护路径。

结合临床医师访谈、二手文献综述和迭代式同侪检验的综合调查方法，确保了研究结果具有丰富的背景资讯和实际应用价值。

本分析的调查方法融合了第一手资料和第二手资料、定性专家访谈以及迭代检验，以确保获得稳健且富含背景资讯的洞见。第一手资料包括与介入性心臟病专家、血管外科医生、导管室主任、采购人员和门诊手术中心管理人员进行结构化访谈和讨论，以收集关于器械性能、手术流程和实施障碍的第一手资讯。除了这些以临床医生为中心的对话外，还采访了监管和报销方面的专家，以揭示影响器械应用的政策因素和采购趋势。

这项二次研究对同行评审文献、临床指南、手术登记资料和产品技术规格进行了系统性回顾，旨在阐明该器械在冠状动脉和周边血管领域的作用机制、安全性以及临床应用案例。分析还考虑了器械适应症、监管核准情况和已发表的临床结果数据，以便更好地理解临床发现。研究采用定性综合方法，旨在调和医疗专业人员之间有时存在的衝突观点，并提炼出关于培训需求、辅助技术以及器械在临床实践中的适用性的通用主题。

最后，研究结果检验。这种三角验证的调查方法确保了结论能够反映当前临床实际情况、运营限制以及包括门诊手术中心、医院和专科诊所（如门诊血管中心和血管实验室）在内的相关人员的战略重点。

综合分析临床需求、营运实际情况和策略性商业性合作将如何推动动脉粥状硬化斑块切除术的下一阶段应用，并得出相关结论。

对器械机制、临床路径、区域趋势和商业策略的累积分析表明，动脉粥状硬化斑块切除术器械正从小众工具转变为主导通讯协定血管治疗方案为导向的关键组成部分。临床团队将继续寻求能够针对不同病变类型提供可预测性能、与影像和栓塞保护策略无缝衔接，并提供培训资源以减少治疗结果差异的平台。在营运方面，随着某些手术转向门诊和当日出院模式，支持手术量、安全性和当日出院流程的器械将日益受到重视。

在商业方面，能够将产品创新与强大的售后支援、灵活的采购模式以及有针对性的证据生成相结合的製造商，将更有利于影响医疗器材的长期选择。近期政策变更导致的供应链调整凸显了采购弹性和服务型交付模式对于维持医疗连续性的重要性。展望未来，临床领导者、医疗设备製造商和医疗系统之间的合作将塑造动脉粥状硬化斑块切除术应用和标准化的下一阶段，重点是治疗效果、成本效益和临床医生的熟练程度。

在这个不断变化的环境中取得成功，取决于将临床疗效、营运适应性和策略商业性参与相结合，从而在应对现代医疗保健服务的实际限制的同时，实现患者照护的可衡量改进。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在周边动脉疾病的治疗中，结合动脉粥状硬化斑块切除术和药物释放型球囊疗法的联合器械的应用日益增多。
  • 对具备整合成像功能以进行复杂病变导航的定向动脉粥状硬化斑块切除术系统的需求日益增长
  • 开发具有自动斑块减少功能和更高安全性的新一代轨道动脉粥状硬化斑块切除术装置
  • 人们对微创导管动脉动脉粥状硬化斑块切除术治疗膝下慢性完全闭塞的兴趣日益浓厚
  • 新型雷射辅助斑块修饰技术拓展了冠状动脉介入治疗中动脉粥状硬化斑块切除术的适应症。
  • 新兴的混合式动脉粥状硬化斑块切除术平台结合了雷射和机械方式，用于治疗钙化病变

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依器械类型动脉粥状硬化斑块切除术的动脉粥状硬化切除器械市场

  • 定向
  • 雷射
  • 轨道
  • 旋转

第九章 依应用分類的动脉动脉粥状硬化斑块切除术市场

  • 冠状动脉
  • 外围
    • 颈动脉
    • 下肢
      • 腘动脉
      • 股浅动脉

第十章 依最终用户分類的动脉动脉粥状硬化斑块切除术器械市场

  • 门诊手术中心
  • 医院
  • 专科诊所
    • 门诊血管中心
    • 血管检查室

第十一章 依模式类型分類的动脉动脉粥状硬化斑块切除术器械市场

  • 常用表达
  • 间歇性

第十二章 按地区分類的动脉动脉粥状硬化斑块切除术器械市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 依组别分類的动脉动脉粥状硬化斑块切除术器械市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国动脉动脉粥状硬化斑块切除术器材市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Medtronic plc
    • Koninklijke Philips NV
    • Cardiovascular Systems, Inc.
    • AngioDynamics, Inc.
    • Terumo Corporation
    • Becton, Dickinson and Company
    • OrbusNeich Medical Company Limited
    • ConMed Corporation
Product Code: MRR-8E22B61932A8

The Atherectomy Devices Market is projected to grow by USD 2.02 billion at a CAGR of 8.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.03 billion
Estimated Year [2025] USD 1.12 billion
Forecast Year [2032] USD 2.02 billion
CAGR (%) 8.69%

Comprehensive introduction to how device innovation, clinical practice shifts, and care pathway demands are reshaping the atherectomy landscape for interventional specialists

Atherectomy devices occupy a pivotal role in contemporary peripheral and coronary interventional practice, addressing calcified and complex atherosclerotic lesions where conventional balloon angioplasty and stenting may be insufficient. The clinical imperative for precision plaque modification, coupled with procedural efficiency and the desire to minimize downstream complications, has driven continuous device evolution. Innovations span mechanical, directional, orbital, and laser-based systems, each engineered to meet distinct lesion morphology and anatomic challenges while aligning with operator preferences and institutional workflows.

Beyond device mechanics, stakeholder expectations now encompass integrated solutions that reduce procedure time, mitigates embolic risk, and facilitate same-day discharge pathways. Reimbursement environments, procedural guidelines, and growing demand for ambulatory-based interventions are reshaping where and how these devices are deployed. As clinical teams pursue optimal patient outcomes, they increasingly weigh comparative procedural safety, ease of use, training needs, and post-procedural care implications when selecting atherectomy approaches.

The introduction of next-generation mode strategies, including continuous and intermittent operation types, and the refinement of adjunctive technologies such as embolic protection and intravascular imaging, further diversify the decision matrix. Consequently, device manufacturers, clinical leaders, and health system purchasers must navigate a nuanced landscape where clinical efficacy, operational adaptability, and regulatory alignment determine the strategic choices that influence procedural pathways and patient care trajectories.

How clinical imaging, outpatient care trends, and device mechanism differentiation are driving a fundamental shift in atherectomy procedural strategies and adoption dynamics

Transformative shifts in the atherectomy domain reflect a confluence of clinical, technological, and care-delivery trends that are redefining procedural paradigms. Clinicians are adopting more precise lesion-preparation strategies as intravascular imaging and physiologic assessment tools inform device selection, thereby promoting tailored approaches that match device mechanism to plaque composition. This has elevated the importance of device differentiation across directional, laser, orbital, and rotational systems, with each class carving specific clinical niches based on lesion complexity and anatomical considerations.

Simultaneously, care-delivery models are moving toward outpatient and ambulatory settings, prompting device development to prioritize user ergonomics, reduced procedure duration, and compatibility with same-day discharge protocols. The interplay between device mode types-continuous versus intermittent-affects heat generation, debris management, and operator technique, prompting manufacturers to innovate around safety features and adjunctive embolic-protection strategies. Furthermore, cross-disciplinary collaboration between vascular surgeons, interventional cardiologists, and radiologists is accelerating hybrid procedural approaches that leverage complementary device platforms.

On the commercial front, competitive dynamics are intensifying as companies emphasize service offerings, training programs, and bundled solutions to lower adoption barriers. Regulatory scrutiny and evolving reimbursement frameworks have also prompted companies to demonstrate clear clinical value propositions and to invest in real-world evidence generation. Collectively, these shifts are expanding the operational role of atherectomy devices beyond niche interventions into broader, protocol-driven care pathways that prioritize predictable outcomes and procedural efficiency.

Operational and procurement implications of the United States tariff changes in 2025 that are reshaping sourcing, manufacturing, and clinical adoption pathways for device stakeholders

United States tariff changes enacted in 2025 have imposed tangible operational considerations across medical device supply chains, affecting components, capital equipment imports, and peripheral consumables integral to atherectomy systems. The tariff adjustments have prompted manufacturers to re-evaluate sourcing strategies, prioritize regional supply continuity, and accelerate discussions with contract manufacturers to insulate production timelines. This recalibration has been most pronounced for companies that rely on specialized components or assembly operations located outside the United States, prompting nearshoring and diversification of supplier portfolios.

In response, procurement teams at hospitals, ambulatory surgical centers, and specialty clinics have increased focus on inventory management, contract terms, and total cost of ownership when selecting device platforms. Device makers have pursued cost optimization through recalibrated bills of materials, design simplification where clinically feasible, and selective localization of high-value components. These measures have been complemented by intensified dialogues between manufacturers and health systems to explore consignment models, managed inventory programs, and bundled purchasing arrangements that mitigate tariff-driven price volatility.

The policy shift has also stimulated renewed emphasis on lifecycle support and service-based revenue streams, as companies seek to sustain margins while offering predictable procurement options. Importantly, clinicians and supply chain leaders are working together to ensure that clinical efficacy and patient safety remain paramount while navigating operational adjustments prompted by the tariff landscape, leading to pragmatic trade-offs and phased implementation strategies for devices and consumables.

Key segmentation insights revealing how device mechanism, clinical indication, care setting, and operational mode collectively shape clinical adoption and commercial positioning

Segmentation insights reveal nuanced adoption dynamics across device types, clinical applications, end-user settings, and mode types that inform both clinical strategy and commercial focus. Device-type distinctions between directional, laser, orbital, and rotational systems reflect divergent operational profiles: directional systems are often favored for precise plaque modification in eccentric lesions, laser systems provide unique advantages in certain fibro-calcific anatomies, orbital platforms enable circumferential plaque sanding with differential cutting action, and rotational systems are commonly chosen for their familiarity and established performance in select lesion sets. These mechanistic differences shape training requirements, procedure planning, and adjunctive device selection.

Application segmentation underscores distinct coronary and peripheral pathways. Coronary interventions typically prioritize lumen restoration in small-caliber, high-flow vessels, whereas peripheral procedures demand versatility across larger vessels and varied lesion morphologies. Within the peripheral pathway, specific attention to carotid interventions and lower limb arteries directs clinical decision-making; lower limb strategies further differentiate between popliteal artery and superficial femoral artery interventions due to anatomic mobility, vessel size, and biomechanical stressors. End-user segmentation highlights the influence of care setting on device choice and procedural logistics. Ambulatory surgical centers emphasize throughput and same-day discharge compatibility, hospitals prioritize range of device capabilities and backup resources, and specialty clinics focus on vascular-centric workflows; within specialty clinics, outpatient vascular centers and vascular labs each face different staffing and imaging infrastructure considerations that influence device deployment.

Mode type segmentation between continuous and intermittent operation influences procedural technique and safety profiles. Continuous systems can offer steady-state performance suitable for specific plaque morphologies, while intermittent systems may provide thermal management advantages and different debris characteristics. Collectively, these segmentation layers inform go-to-market strategies, clinical training programs, and the development of value propositions tailored to the unique demands of operators and institutions across clinical and geographic contexts.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine clinical pathways, regulatory approaches, and commercial engagement strategies

Regional dynamics exert a powerful influence on clinical practice patterns, regulatory approaches, and commercial strategies for atherectomy devices, with distinct characteristics observable across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, clinical pathways are shaped by advanced endovascular programs and established networks of interventional specialists, leading to high procedural volumes in tertiary hospitals and growing throughput in ambulatory settings. Reimbursement frameworks and supply chain considerations within this region influence procurement cadence and favor partners that can provide robust training and lifecycle support.

The Europe, Middle East & Africa region displays heterogeneous regulatory environments and healthcare delivery models, which necessitate adaptable market approaches. Western European centers typically emphasize evidence-based adoption, integration with intravascular imaging, and multidisciplinary procedural planning, while other markets within the broader region may prioritize cost-effective solutions and scalable training programs. Regulatory timelines and national procurement practices are critical variables that shape entry strategies and product positioning.

Asia-Pacific presents diverse opportunities driven by expanding cardiovascular care infrastructure, rapid adoption of minimally invasive techniques, and a mix of public and private healthcare delivery. In several markets, increasing procedure volumes for peripheral arterial disease and investments in catheterization facilities are creating demand for versatile device portfolios. Across all regions, manufacturers and clinical leaders must reconcile global product platforms with local clinical workflows, regulatory requirements, and reimbursement realities, employing differentiated engagement models that align training, service, and commercial support with regional priorities.

How manufacturers are competing through clinical training, service models, and integrated platform strategies to influence procedural adoption and long-term customer relationships

Competitive dynamics among device manufacturers now hinge on more than device mechanics; they encompass training, evidence generation, post-market surveillance, and integrated service offerings. Leading companies are investing in clinical education programs, hands-on training for interventional teams, and digital tools that support patient selection and procedural planning. These capabilities help lower barriers to adoption and increase procedural confidence among operators transitioning between device classes. Strategic partnerships and distribution models are also evolving, with manufacturers collaborating with health systems, training centers, and imaging vendors to create bundled solutions that address entire procedural pathways from planning through follow-up.

Product development investments are channeling into platform versatility, adjunctive safety features such as embolic-protection compatibility, and minimally invasive access enhancements. Companies are also leveraging real-world evidence initiatives and registry participation to strengthen clinical narratives and to support payer discussions centered on outcomes and resource utilization. Service differentiation through managed inventory, on-site technical support, and outcome-focused training has become a key competitive lever, especially in settings where procedural throughput and cost predictability influence purchasing decisions.

Given the intersection of clinical requirements and operational constraints, market players that align product design, clinician training, and post-sales support with institutional workflows are best positioned to influence long-term procurement decisions. Those that emphasize interoperability with intravascular imaging and ancillary devices, demonstrate reproducible clinical outcomes, and deliver scalable education programs will maintain a durable advantage in complex account environments.

Actionable recommendations for device makers and clinical leaders to align training, supply-chain resilience, and evidence generation with regional care delivery priorities

Industry leaders should adopt a multi-pronged approach that aligns device innovation with clinical education, regional adaptability, and resilient supply chains. First, prioritize investments in comprehensive clinician training programs that combine simulation, proctorship, and case-based learning to accelerate safe adoption across directional, laser, orbital, and rotational platforms. Embedding intravascular imaging training alongside device education will help clinicians optimize patient selection and procedural techniques, reducing variability in outcomes and building stronger clinical evidence for device-specific approaches.

Second, bolster supply-chain resilience by diversifying component sourcing, considering nearshoring of critical assemblies, and negotiating flexible procurement terms with health-system partners. These actions will mitigate the operational uncertainties introduced by trade-policy shifts and support predictable device availability. Third, tailor regional strategies to local regulatory and reimbursement landscapes by offering adaptable commercial models such as managed inventory, outcome-based contracting pilots, and localized service hubs that address the unique needs of ambulatory surgical centers, hospitals, and specialty clinics, including outpatient vascular centers and vascular labs.

Fourth, invest in real-world evidence programs and registries that capture procedural outcomes across coronary and peripheral indications, with attention to lesion subsets such as carotid and lower limb interventions involving the popliteal artery and superficial femoral artery. Finally, design product roadmaps that balance performance improvements with simplicity of use, emphasizing safety features for continuous and intermittent mode types to meet diverse operator preferences. This integrated approach will help manufacturers and clinical leaders translate innovation into sustainable adoption and improved patient care pathways.

Integrated research methodology combining clinician interviews, secondary literature review, and iterative expert validation to ensure context-rich and actionable insights

The research methodology underpinning this analysis integrates a blended approach of primary and secondary investigation, qualitative expert engagement, and iterative validation to ensure robust, context-rich insights. Primary inputs included structured interviews and consultations with interventional cardiologists, vascular surgeons, cath lab directors, procurement leaders, and ambulatory surgical center managers to capture firsthand perspectives on device performance, procedural workflow, and adoption barriers. These clinician-centered dialogues were complemented by interviews with regulatory and reimbursement specialists to illuminate policy drivers and procurement dynamics that influence device deployment.

Secondary research encompassed a systematic review of peer-reviewed literature, clinical guidelines, procedure registries, and product technical specifications to map device mechanisms, safety profiles, and clinical use cases across coronary and peripheral applications. The analysis also considered device labeling, regulatory clearances, and published outcomes data to contextualize clinical narratives. Qualitative synthesis methods were applied to reconcile sometimes divergent practitioner perspectives and to surface common themes related to training needs, adjunctive technologies, and care-setting suitability.

Finally, findings were iteratively validated through expert panel reviews and cross-checked against publicly available clinical evidence and procedural best-practice guidance. This triangulated methodology ensured that conclusions reflect current clinical realities, operational constraints, and the strategic priorities of stakeholders across ambulatory surgical centers, hospitals, and specialty clinics including outpatient vascular centers and vascular labs.

Synthesis and concluding perspectives on how clinical demand, operational realities, and strategic commercial engagement will drive the next phase of atherectomy adoption

The cumulative analysis of device mechanisms, clinical pathways, regional dynamics, and commercial strategies indicates that atherectomy devices are transitioning from niche tools to strategic components of protocol-driven vascular care. Clinical teams will continue to demand platforms that offer predictable performance across diverse lesion types, seamless integration with imaging and embolic-protection strategies, and training resources that reduce variability in outcomes. Operationally, the migration of selected procedures to ambulatory and outpatient environments will place a premium on devices that support throughput, safety, and same-day discharge workflows.

Commercially, manufacturers that combine product innovation with robust post-sales support, flexible procurement models, and targeted evidence generation will be better positioned to influence long-term device selection. Supply-chain adjustments prompted by recent policy changes highlight the importance of sourcing flexibility and service-based offerings that maintain continuity of care. Looking ahead, collaborative initiatives between clinical leaders, device makers, and health systems that emphasize outcomes, cost efficiency, and clinician proficiency will shape the next phase of atherectomy adoption and standardization.

Ultimately, success in this evolving landscape will depend on the alignment of clinical efficacy, operational adaptability, and strategic commercial engagement to deliver measurable improvements in patient care while accommodating the practical constraints of contemporary healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of combination devices integrating atherectomy with drug-coated balloon therapy in peripheral arterial disease management
  • 5.2. Rising demand for directional atherectomy systems with integrated imaging for complex lesion navigation
  • 5.3. Development of next-generation orbital atherectomy devices with automated plaque debulking and enhanced safety features
  • 5.4. Growing focus on minimally invasive catheter-based atherectomy for below-the-knee chronic total occlusions
  • 5.5. Expansion of atherectomy use in coronary interventions driven by novel laser-assisted plaque modification techniques
  • 5.6. Emergence of hybrid atherectomy platforms combining laser and mechanical modalities for calcified lesion treatment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Atherectomy Devices Market, by Device Type

  • 8.1. Directional
  • 8.2. Laser
  • 8.3. Orbital
  • 8.4. Rotational

9. Atherectomy Devices Market, by Application

  • 9.1. Coronary
  • 9.2. Peripheral
    • 9.2.1. Carotid
    • 9.2.2. Lower Limb
      • 9.2.2.1. Popliteal Artery
      • 9.2.2.2. Superficial Femoral Artery

10. Atherectomy Devices Market, by End-User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospitals
  • 10.3. Specialty Clinic
    • 10.3.1. Outpatient Vascular Center
    • 10.3.2. Vascular Lab

11. Atherectomy Devices Market, by Mode Type

  • 11.1. Continuous
  • 11.2. Intermittent

12. Atherectomy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Atherectomy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Atherectomy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Boston Scientific Corporation
    • 15.3.2. Abbott Laboratories
    • 15.3.3. Medtronic plc
    • 15.3.4. Koninklijke Philips N.V.
    • 15.3.5. Cardiovascular Systems, Inc.
    • 15.3.6. AngioDynamics, Inc.
    • 15.3.7. Terumo Corporation
    • 15.3.8. Becton, Dickinson and Company
    • 15.3.9. OrbusNeich Medical Company Limited
    • 15.3.10. ConMed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ATHERECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ATHERECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ATHERECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. GCC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GCC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GCC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. GCC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. GCC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. GCC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. GCC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 276. GCC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 277. GCC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 278. GCC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 279. GCC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 280. GCC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 281. GCC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 282. GCC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 283. GCC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GCC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 311. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 312. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. G7 ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. G7 ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. G7 ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. G7 ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. G7 ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. G7 ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. G7 ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 324. G7 ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 325. G7 ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 326. G7 ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2025-2032 (USD MILLION)
  • TABLE 327. G7 ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 328. G7 ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 329. G7 ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 330. G7 ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 331. G7 ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. NATO ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. NATO ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. NATO ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. NATO ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. NATO ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. NATO ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. NATO ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 340. NATO ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 341. NATO ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2024 (USD MILLION)
  • TABLE 342. NATO ATHERECTOMY DEVICES MARKET SIZ